AMICUS THERAPEUTICS INC
Industry: Life Sciences ・ $FOLD on Nasdaq
Insider Sale
+$77,550
-0.84%
Shares
Shares Volume: 7,500 Shares
Average Share Price: $10.34
INSIDER
Campbell Bradley L
President and CEO (Director)
reported on Aug 5 2024
traded on Aug 1 2024
TRADE ACTIVITY 1Y
current insider trade in blue
INSIDER ACTIVITY
| NEW SHARES OWNERSHIP AMOUNT | 886,654 |
| PURCHASES/SALES 1Y | 0 / 12 |
| P/S VALUE RATIO | N/A |
| AVERAGE SALE VALUE | $136,453.25 |
| INSIDER PREVIOUS TRADES |
COMPANY OVERALL ACTIVITY
INSIDERS IN PAST 2 WEEKS with at least one purchase / sale | 0 / 1 |
| PURCHASES/SALES 1Y | 0 / 38 |
| P/S VALUE RATIO | N/A |
| AVERAGE SALE VALUE | $228,562.52 |
| COMPANY PREVIOUS TRADES |